The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Q.-W.
Right arrow Articles by Fairchild, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Q.-W.
Right arrow Articles by Fairchild, R. L.
The Journal of Immunology, 2003, 170: 5530-5537.
Copyright © 2003 by The American Association of Immunologists

Absence of Allograft ICAM-1 Attenuates Alloantigen-Specific T Cell Priming, But Not Primed T Cell Trafficking into the Graft, to Mediate Acute Rejection1

Qi-Wei Zhang*, Danielle D. Kish* and Robert L. Fairchild2,*,{dagger},{ddagger}

* Department of Immunology and {dagger} Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195; and {ddagger} Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106

The expression and function of ICAM-1 are critical components in the initiation and elicitation of many T cell-mediated responses. Whether ICAM-1 expression is required on the T cells or on the APC during T cell priming remains unclear. To address this issue in alloantigen-specific T cell activation, the priming and function of T cells in response to heart allografts from MHC-mismatched wild-type vs ICAM-1-/- donors were tested. Wild-type C57BL/6 (H-2b) heart allografts were rejected by A/J (H-2a) recipients on days 7–9, whereas B6.ICAM-1-/- allografts survived until days 18–23 post-transplant. On day 7 post-transplant, infiltrating macrophages and CD4+ and CD8+ T cells in the ICAM-1-/- allografts were 20–30% those observed in the wild-type allografts. ELISPOT analyses indicated that the number of alloantigen-specific T cells producing IFN-{gamma} from recipients of ICAM-1-deficient grafts was 60% lower than that from recipients of wild-type allografts. On day 16 post-transplant, these numbers did not markedly increase in ICAM-1-deficient allograft recipients. Consistent with the reduced priming of alloreactive T cells, isolated dendritic cells from ICAM-1-/- mice stimulated allogeneic T cell proliferation poorly compared with wild-type dendritic cells. When A/J mice were primed with wild-type dendritic cells and then received wild-type or ICAM-1-deficient heart allografts 3 days later, the primed recipients rejected the wild-type and ICAM-1-/- allografts on days 5–6 post-transplant. These results indicate that optimal priming of alloreactive T cells requires allograft expression of ICAM-1, but, once primed, recipient T cell infiltration into the allograft is independent of graft ICAM-1 expression.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. B. Auerbach, N. Shimoda, H. Amano, J. M. Rosenblum, D. D. Kish, J. M. Farber, and R. L. Fairchild
Monokine Induced by Interferon-{gamma} (MIG/CXCL9) Is Derived from Both Donor and Recipient Sources during Rejection of Class II Major Histocompatibility Complex Disparate Skin Allografts
Am. J. Pathol., June 1, 2009; 174(6): 2172 - 2181.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Gueler, S. Rong, M. Mengel, J.-K. Park, J. Kiyan, T. Kirsch, I. Dumler, H. Haller, and N. Shushakova
Renal Urokinase-Type Plasminogen Activator (uPA) Receptor but not uPA Deficiency Strongly Attenuates Ischemia Reperfusion Injury and Acute Kidney Allograft Rejection
J. Immunol., July 15, 2008; 181(2): 1179 - 1189.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Graf, T. Bushnell, and J. Miller
LFA-1-Mediated T Cell Costimulation through Increased Localization of TCR/Class II Complexes to the Central Supramolecular Activation Cluster and Exclusion of CD45 from the Immunological Synapse
J. Immunol., August 1, 2007; 179(3): 1616 - 1624.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Kosuge, G. Haraguchi, N. Koga, Y. Maejima, J.-i. Suzuki, and M. Isobe
Pioglitazone Prevents Acute and Chronic Cardiac Allograft Rejection
Circulation, June 6, 2006; 113(22): 2613 - 2622.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Amano, A. Bickerstaff, C. G. Orosz, A. C. Novick, H. Toma, and R. L. Fairchild
Absence of Recipient CCR5 Promotes Early and Increased Allospecific Antibody Responses to Cardiac Allografts
J. Immunol., May 15, 2005; 174(10): 6499 - 6508.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Schenk, D. D. Kish, C. He, T. El-Sawy, E. Chiffoleau, C. Chen, Z. Wu, S. Sandner, A. V. Gorbachev, K. Fukamachi, et al.
Alloreactive T Cell Responses and Acute Rejection of Single Class II MHC-Disparate Heart Allografts Are under Strict Regulation by CD4+CD25+ T Cells
J. Immunol., March 15, 2005; 174(6): 3741 - 3748.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Michailowsky, M. R. N. Celes, A. P. Marino, A. A. Silva, L. Q. Vieira, M. A. Rossi, R. T. Gazzinelli, J. Lannes-Vieira, and J. S. Silva
Intercellular Adhesion Molecule 1 Deficiency Leads to Impaired Recruitment of T Lymphocytes and Enhanced Host Susceptibility to Infection with Trypanosoma cruzi
J. Immunol., July 1, 2004; 173(1): 463 - 470.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.